Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.71774 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.70329 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.70393 | 31 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.62612 | 30 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.65996 | 31 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.79219 | 32 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.70332 | 29 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.68377 | 31 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.66535 | 30 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.68513 | 31 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.68695 | 31 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.66766 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.69795 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.69475 | 31 |